Chinese Pharmaceuticals & Biotech High ROE Growth Engines

Shanghai Allist Pharmaceuticals

Market Cap: CN¥38.5b

A pharmaceutical company, engages in the research and development of tumor-targeted drugs in China in internationally.

Sunshine Guojian Pharmaceutical (Shanghai)

Market Cap: CN¥37.0b

A biopharmaceutical company, engages in the research and development, production, and sale of antibody drugs.

Tianjin Pharmaceutical Da Ren Tang Group

Market Cap: CN¥25.6b

Engages in the research, development, processing, manufacturing, and sale of traditional Chinese medicine in China.

Xiamen Amoytop Biotech

Market Cap: CN¥22.0b

Engages in research, development, production, and sale of recombinant protein drugs in China and internationally.

Shenyang Xingqi PharmaceuticalLtd

Market Cap: CN¥13.2b

Engages in the research, development, production, and sale of ophthalmic drugs in the People’s Republic of China.